Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know
06:51pm, Tuesday, 23'rd Dec 2025
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $56.46, marking a -2.5% move from the previous day.
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
02:18pm, Tuesday, 23'rd Dec 2025
CRISPR Therapeutics has figured out a way to successfully repair genetic code. Monetizing this know-how is the next step.
CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies
11:35am, Tuesday, 23'rd Dec 2025
CRISPR Therapeutics shares jump after early zugo-cel study data show sustained B-cell depletion and early efficacy across autoimmune and cancer studies.
CRISPR Therapeutics CRISPR Therapy Shows 90% Response Rate In Aggressive Blood Cancer
12:45pm, Monday, 22'nd Dec 2025
CRISPR Therapeutics AG (NASDAQ: CRSP) on Monday provided updates on zugocaptagene geleucel (zugo-cel, formerly CTX112), its investigational allogeneic CAR T targeting CD19, in development for autoimmu
-Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy data suggest significant clinical improvement in patients dosed at the 100
Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?
10:01am, Friday, 19'th Dec 2025
Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026?
06:45am, Friday, 19'th Dec 2025
CRISPR has incurred nearly $500 million in losses over the past four quarters. It's burning through cash as the result of its its gene-editing therapy's slow rollout.
2 Growth Stocks to Invest $1,000 in Right Now
12:15pm, Thursday, 18'th Dec 2025
A $1,000 investment can be an ideal amount to invest in an up-and-coming growth stock. The stocks below are still modest in size, with market capitalization of less than $6 billion.
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know
06:51pm, Wednesday, 17'th Dec 2025
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $54.74, indicating a -2.2% shift from the previous trading day.
2 Monster Stocks in the Making to Buy and Hold
10:30am, Tuesday, 16'th Dec 2025
The next 12 months will tell us more about their prospects.
12 Days of Investing: My Top 12 Stocks to Buy Before 2026
11:10am, Monday, 15'th Dec 2025
There are only 12 investing days left in 2025. Now is a great time to load up on stocks that may win next year -- and over time.
2 Healthcare Stocks to Buy Ahead of the New Year
12:45pm, Friday, 12'th Dec 2025
CRISPR Therapeutics could soar on the back of significant pipeline progress next year. Vertex's slow and steady approach to diversifying its lineup should eventually pay off.
Why Is CRISPR Therapeutics (CRSP) Up 3.3% Since Last Earnings Report?
12:30pm, Wednesday, 10'th Dec 2025
CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock?
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
10:01am, Monday, 08'th Dec 2025
Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Stocks That Could Soar by 52% and 282%, According to Wall Street
09:25am, Sunday, 07'th Dec 2025
CRISPR Therapeutics' approved medicine is making slow progress, but it has an exciting pipeline. Iovance Biotherapeutics is generating decent revenue, but it faces significant obstacles.
